logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Hexadecanedioic Acid CAS 505-54-4 White Powder 99%

Hexadecanedioic Acid CAS 505-54-4 White Powder 99%

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO

Model Number: 505-54-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 working days

Payment Terms: L/C,D/A,D/P,T/T,Western Union

Supply Ability: Ton

Get Best Price
Highlight:

Hexadecanedioic Acid white powder

,

Hexadecanedioic Acid 99% purity

,

Pharmaceutical API Hexadecanedioic Acid

CAS No::
505-54-4
Appearance::
White Powder
Molecular Formula::
C16H30O4
Molecular Weight::
286.41
EINECS NO::
208-013-5
MDL NO.::
MFCD00002746
CAS No::
505-54-4
Appearance::
White Powder
Molecular Formula::
C16H30O4
Molecular Weight::
286.41
EINECS NO::
208-013-5
MDL NO.::
MFCD00002746
Hexadecanedioic Acid CAS 505-54-4 White Powder 99%
Hexadecanedioic Acid CAS 505-54-4
Product Description

Chemical Name: Hexadecanedioic Acid
CAS Number: 505-54-4

Synonyms
  • Thapsic Acid
  • Hexadecane-1,16-dioic acid
  • n-Tetradecane-omega,omega'-dicarboxylic acid
Chemical & Physical Properties
Property Value
Appearance White powder
Assay ≥99%
Melting Point 120-123℃
Boiling Point 457.5±18.0 °C at 760 mmHg
Flash Point 244.6℃
Density 1.0351 (rough estimate)
Vapor Pressure 0Pa at 25 ℃
Refractive Index 1.4485 (estimate)
Storage Conditions Store below +30 ℃
Solubility Soluble in DMSO (in small amounts) and methanol (in small amounts)
Form Solid
Acidity Coefficient (pKa) 4.48±0.10 (Predicted)
Water Solubility 5.098mg/L at 20 ℃
BRN 1792831
Stability Stable. Incompatible with alkali, oxidants and reductants. Flammable.
InChIKey YGMGJMSLLNODQV-UHFFFAOYSA-N
LogP 4.67 at 25℃
Safety Information
Category Information
Risk Statements R36/37/38
Safety Instructions S24/25
WGK Germany 3
HS Code 29171900
Applications
  • Useful research intermediate for the study of human blood pressure regulation
  • In combination with SLCO1B1, serves as a potential therapy for statins
Note: Products under patent are offered for R&D purposes only. The final responsibility lies exclusively with the buyer.

For product inquiries or additional information, please contact our technical team.